The present invention is self-skin, by measuring the skin self-fluorescence from such an advanced glycation end product (Advanced Glycation End products, AGE) accumulated in the skin to perform the evaluation for a variety of diseases such as diabetes which can measure fluorescence It relates to a fluorescence measurement device. To this end, in the present invention, in the measurement of skin fluorescence, irradiation the transmitted light of the light surface of the skin, and light scattering and absorbing the transmitted light detection type skin fluorescence measurements can simply correct the measurement errors of the skin fluorescence due to occurring in the skin and to provide a device. In the present invention, is configured for a standard specimen or a measurement object to be detected light irradiation and the light, a first light source for irradiating the excitation light, and a second light source for irradiating the first light source and another light having a different wavelength, wherein first light source and the second is arranged to be able to detect the transmitted light from the second light source, and the first optical detector and the second optical detector to detect the two different wavelengths for the fluorescent signal and the transmitted light signal, the first light source and the second and a light source switching control unit for controlling on / off of the light source, comprising: a computing unit for calculating the first optical detector and the second skin fluorescence signal correction from the fluorescent signal and the transmitted light signal detected from the photodetector, the second light source is It provides a transmitted light detection type skin fluorescence measurement device characterized in that the irradiating light wavelength range of fluorescence of the skin which is excited by the excitation light from the first light source emits.본 발명은 피부에 축적된 최종당화산물(Advanced Glycation End products, AGE) 등으로부터의 피부의 자가형광을
